Jeroen van de Pol

87 4 CHAPTER 4 Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study Sanne Verdoorn* Jeroen M. van de Pol* Anke M. Hövels Henk-Frans Kwint Jeanet W. Blom Jacobijn Gussekloo Marcel L. Bouvy * Equal contribution. British Journal of Clinical Pharmacology 2021;87:588-97.